Hot News

沛嘉醫療熱爆吸560億孖展首日超購238倍反應勝康方生物 @ 2020-05-06T20: Back Hot News
Keyword:孖展 首日 沛嘉醫療 超購 經濟
Concept:沛嘉首日孖展 , 沛嘉醫療首日招股超購
【本報訊】資金轉吼新股市場,醫療器械公司沛嘉醫療(9996)及物管股建業新生活(9983)昨日同步開始招股,前者出閘即搶盡風頭。沛嘉首日錄逾560億元孖展,以公開 ...
【明報專訊】未盈利生科股浪潮愈炒愈高,昨日起招股的醫械股沛嘉醫療(9996)首日錄券商借出孖展530億元,成今年首日吸金最多的新股,更有望挑戰康方 ...
本地傳媒引述消息指,昨日(5日)起招股的無收入生物科技上市公司沛嘉醫療(09996.HK)已錄得近521億元孖展,相當於其公開發售部份超購221倍,並錄得超過10張「 ...
無收入生物科技上市公司(B股)熱潮停不了!沛嘉醫療(09996)昨天首日招股已獲投資者重錘出擊,綜合5家券商已合共借出近521億元孖展額,相當於公開發售超 ...
【新增內容】○新股熱潮再現,沛嘉醫療(9996)及建業新生活(9983)今日起公開招股,分別集資最多23.5億及21.6億元,其中沛嘉醫療首日認購氣氛熾熱,據了解至少兩 ...
內地經導管心髒瓣膜醫療器械生產商沛嘉醫療(9996) 計劃集資最多23.4億元,每股招股價15.36元,總發售1.525億股。預計一手1000股,入場費為15515.
內地經導管心髒瓣膜醫療器械生產商沛嘉醫療(新上市編號:09996)計劃發售1.525億股,每股招股價15.36元,集資最多23.4億元,一手(1000股)入場費15515元, ...
沛嘉醫療(新上市編號:09996)首日招股,券商首日已錄強勁孖展認購,當中輝立孖展達200億元、耀才孖展達150億元、信誠孖展達105億元,首日整體市場的孖展額 ...
【財華社訊】沛嘉醫療-B(09996-HK)公布公開招股計劃,該公司今起至5月8日,以每股每股發售股份15.36港元公開發售1.52511億股股份,其中1.37259億股股份是 ...
無收入生物科技上市公司(B股)熱潮停不了!沛嘉醫療(09996)昨天首日招股已獲投資者重錘出擊,綜合5家券商已合共借出近521億元孖展額,相當於公開發售超 ...

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.